Lausanne Lifesciences Expansion Panel
Interactive Networking Panel, live in Hammersmith London, 15 September, 17:30-19:30 GMT
The lucrative Life Sciences ecosystems in Lausanne, Switzerland, given the uncertainties elsewhere, provide a set of great and tangible opportunities for UK companies for international growth. At the heart of the Swiss ‘Health Valley’ , an ecosystem gathering 1200+ companies in Pharma, Biotech, MedTech and Digital Health business, The Lausanne region offers direct access to multiple global corporations including Medtronic, Merck, Incyte, Beckton Dickinson, Intuitive Surgical, Ferring and Nestlé Health Science who can access markets across Europe, the Americas and globally.
Program:
17.00: Registration & Networking
17.30: Intro from ARC West London and BioUK representatives
- Jane O’Driscoll, Executive Director & Head of Events, BioUK
- Philippa Clark, Director Business Development, One Nucleus
- Deborah Spencer, ARC West London Health & Tech Cluster Lead
17.45: Moderated panel with representatives from Innovaud, EPFL and life sciences entrepreneurs expanding from the UK to grow in Lausanne
- Moderation: Mark Stimpfig, Strategic Growth Advisor UK, Innovaud
- Frédéric Reymond, Senior Investment Officer, Innovaud
- Marc Reichlin, Trade Commissioner Invest, Embassy of Switzerland in the UK
- Michael Wilkinson, Founder & CEO, Inavya Ventures
- Eric Ménard, Managing Partner, EPFL Innovation Park
- Christopher Rudolf, Founder & CEO, Volv Global
- Loïc Roch, Co-founder & CSO, Atinary Technologies
- Johan Rocher, Co-founder & CTO, Alsensia
18.00-19.00: Networking, finger food and drinks, plus a guided tour of the ARC facilities for any interested delegates .
REGISTER HERE TO SECURE YOUR PLACE: Please note this is an invite only event and places are limited.
FOR MORE INFORMATION. For more information on this interactive panel event and outreach to any of the Lausanne stakeholders please contact Innovaud’s London based advisor, Mark Stimpfig, email (mark@markstimpfig.com) if you are interested in meeting with these Swiss stakeholders.
